Bill is an expert in systems for signal detection and signal management. For more than 15 years his focus has been on systems to improve the assessment and management of drug safety signals. He has had the privilege to work with innovators within regulatory agencies, industry, and academic research groups working with data from single-case adverse event reports, clinical trials, and longitudinal electronic health records.